Yanping Chen

Nov 26, 2024 | journals.plos.org | Jing Zhong |Lin Evlin |Yanping Chen |Chongshu Wu

There are errors in the author affiliations.

Nov 2, 2023 | biorxiv.org | Ritu Bohat |Xiaofang Liang |Yanping Chen |Chunyu Xu

AbstractSle1 and Faslpr are two lupus susceptibility loci that lead to manifestations of systemic lupus erythematosus. To evaluate dosage effects of FASlpr in determining cellular and serological phenotypes associated with lupus, we developed a new C57BL/6 (B6) congenic lupus strain, B6.Sle1/Sle1.Faslpr/+ (sle1homo.lprhet) and compared it with B6.Faslpr/lpr (lprhomo), B6.Sle1/Sle1 (sle1homo), and B6.Sle1/Sle1.Faslpr/lpr (sle1homo.lprhomo) strains.

Mar 28, 2023 | ajo.com | Yanping Chen |Sun Yat-sen |Wei Wang

We read with interest “Choriocapillaris flow deficit as a biomarker for diabetic retinopathy and diabetic macular edema: 3-year longitudinal cohort” by Chen Y et al.(1) With a sample size of 903 despite 18.9 % attrition rate, this is a landmark trial to show a definite association of higher choriocapillaris flow deficit percentage (CCFD%) with diabetic retinopathy (DR) progression and development of diabetic macular edema(DME) over a period of 3 years.